Karbapenem, Genişletilmiş Spektrumlu Beta-Laktam ve Kolistin Dirençli Escherıchıa Colı ve Klebsıella Pneumonıa’ya Tek Sağlık Konseptinde Panoramik Bakış

Authors

Elçin Günaydın
https://orcid.org/0000-0002-5247-7578

Synopsis

Antimicrobial resistance is a major global public health concern threatening human, animal, and environmental health. The increasing prevalence of carbapenem-, extended-spectrum beta-lactam-, and colistin-resistant Escherichia coli and Klebsiella pneumoniae strains has significantly complicated the treatment of bacterial infections. This review discusses the molecular mechanisms of antimicrobial resistance, the epidemiology of resistance genes, and their transmission among humans, animals, and the environment within the One Health framework. Particular attention is given to carbapenemase genes (blaKPC, blaNDM, blaVIM, blaIMP, and blaOXA-48), extended-spectrum beta-lactamase genes (blaTEM, blaSHV, and blaCTX-M), and plasmid-mediated colistin resistance genes (mcr). The roles of chromosomal mutations, porin loss, efflux pumps, and horizontal gene transfer in resistance development are also emphasized. Furthermore, the potential transmission of resistant bacteria of animal origin to humans through the food chain, direct contact, and environmental pathways is emphasized. In conclusion, rational antimicrobial use, improved biosecurity practices, molecular epidemiological investigations, and integrated surveillance programs involving human, animal, and environmental health are essential for controlling antimicrobial resistance.

References

Suay-García B, Pérez-Gracia MT. Present and future of carbapenem-resistant Enterobacteriaceae infections. Advances in Clinical Immunology, Medical Microbiology, COVID-19, and Big Data. 2021;435–456.

Neidhöfer C, Buechler C, Neidhöfer G, Bierbaum G, Hannet I, Hoerauf A, Parčina M. Global distribution patterns of carbapenemase-encoding bacteria in a new light: clues on a role for ethnicity. Frontiers in Cellular and Infection Microbiology. 2021;11:659753

World Health Organization. Global antimicrobial resistance surveillance system (GLASS) report: early implementation 2020. Geneva: World Health Organization; 2020. Licence: CC BY-NC-SA 3.0 IGO

Jeannot K, Bolard A, & Plesiat P. Resistance to polymyxins in Gram-negative organisms. International journal of antimicrobial agents 2017; 49(5), 526-535.

TEPAV 2017 "Türkiye’de Antimikrobiyal Direnç: Ekonomik Değerlendirme ve Öneriler" Raporu www.tepav.org.tr

Bastidas-Caldes C, Cisneros-Vásquez E, Zambrano A, Mosquera-Maza A, Calero-Cáceres W, Rey J, et al. Co-harboring of beta-lactamases and mcr-1 genes in Escherichia coli and Klebsiella pneumoniae from healthy carriers and backyard animals in rural communities in Ecuador. Antibiotics. 2023;12(5):856.

World Health Organization. WHO Bacterial Priority Pathogens List, 2024: bacterial pathogens of public health importance to guide research, development and strategies to prevent and control antimicrobial resistance. Geneva: World Health Organization; 2024. Licence: CC BY-NC-SA 3.0 IGO

Logan LK, Weinstein RA. The epidemiology of carbapenem-resistant Enterobacteriaceae: the impact and evolution of a global menace. The Journal of Infectious Diseases. 2017;215(suppl_1):S28–S36. doi:10.1093/infdis/jiw282

Eisenberger D, Carl A, Balsliemke J, Kämpf P, Nickel S, Schulze G, Valenza G. Molecular characterization of extended-spectrum β-lactamase-producing Escherichia coli isolates from milk samples of dairy cows with mastitis in Bavaria, Germany. Microbial Drug Resistance. 2018;24(4):505–510.

Dinç G, Ata Z, Temelli S. Investigation of extended-spectrum beta-lactamase activity and antibiotic resistance profile of Escherichia coli strains isolated from bovine mastitis. Ankara Üniversitesi Veteriner Fakültesi Dergisi. 2012;59(2).

Bektas A, Guducuoglu H, Gursoy NC, Berktas M, Gultepe B, Parlak M, et al. Investigation of extended spectrum beta-lactamase (ESBL) genes in ESBL-producing Escherichia coli and Klebsiella pneumoniae strains. 2018.

European Committee on Antimicrobial Susceptibility Testing (EUCAST). Breakpoint tables for interpretation of MICs and zone diameters. Version 9.0. 2017. (Eylül 2024 tarihinde http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Breakpoint_tables/v_9.0_Breakpoint_Tables.pdf adresinden ulaşılmıştır)

European Committee on Antimicrobial Susceptibility Testing (EUCAST). EUCAST guidelines for detection of resistance mechanisms and specific resistances of clinical and/or epidemiological importance. Version 2.0. 2019. (Ağustos 2026 tarihinde https://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Resistance_mechanisms/EUCAST_detection_of_resistance_mechanisms_170711.pdf adresinden ulaşılmıştır)

Solgi H, Nematzadeh S, Giske CG, Badmasti F, Westerlund F, Lin YL, et al. Molecular epidemiology of OXA-48 and NDM-1 producing enterobacterales species at a University Hospital in Tehran, Iran, between 2015 and 2016. Frontiers in Microbiology. 2020;11:936.

Teixeira P, Tacão M, Pureza L, Gonçalves J, Silva A, Cruz-Schneider MP, Henriques I. Occurrence of carbapenemase-producing Enterobacteriaceae in a Portuguese river: blaNDM, blaKPC and blaGES among the detected genes. Environmental Pollution. 2020;260:113913.

Hansen GT. Continuous evolution: perspective on the epidemiology of carbapenemase resistance among Enterobacterales and other Gram-negative bacteria. Infectious Diseases and Therapy. 2021;10(1):75–92.

Paveenkittiporn W, Lyman M, Biedron C, Chea N, Bunthi C, Kolwaite A, Janejai N. Molecular epidemiology of carbapenem-resistant Enterobacterales in Thailand, 2016–2018. Antimicrobial Resistance & Infection Control. 2021;10(1):88.

van Duin D, Doi Y. The global epidemiology of carbapenemase-producing Enterobacteriaceae. Virulence. 2017;8(4):460–469.

Sarı AN, Süzük S, Karatuna O, Öğünç D, Karakoç AE, Çizmeci Z. Ülkemizde klinik Enterobacteriaceae izolatlarında plazmit aracılı kolistin direnç genlerini (mcr-1 ve mcr-2) araştıran çok merkezli çalışmaya ait sonuçlar. Mikrobiyol Bul. 2017;51(3):299–303.

Akalın H. Karbapenem Dirençli Enterobacteriaceae Enfeksiyonlarının Tedavisi. Turkiye Klinikleri Infectious Diseases-Special Topics. 2023;16(1):45–60.

Samastı M, Koçoğlu ME, Davarcı İ, Vahapoğlu H, Çaşkurlu H. Karbapenem Dirençli Klebsiella pneumoniae Suşlarında Karbapenemaz Varlığının ve Klonal İlişkinin Araştırılması. 4. Ulusal Klinik Mikrobiyoloji Kongresi, Antalya, Türkiye, 8 - 12 Kasım 2017.

Eren E, Ulu-Kilic A, Ture Z, Cevahir F, Kilic H, Alp-Mese E. Risk factors of mortality in patients with bloodstream infections due to carbapenem resistant Klebsiella pneumoniae. KLIMIK Journal. 2021;34(S1):56–61.

Nurtop E, Bayındır Bilman F, Menekse S, Kurt Azap O, Gönen M, Ergonul O, Can F. Promoters of colistin resistance in Acinetobacter baumannii infections. Microbial Drug Resistance. 2019;25(7):997–1002.

Nordmann P, Naas T, Poirel L. Global spread of carbapenemase-producing Enterobacteriaceae. Emerging Infectious Diseases. 2011;17(10):1791–1798.

Nordmann P, Poirel L. Epidemiology and diagnostics of carbapenem resistance in Gram-negative bacteria. Clinical Infectious Diseases. 2019;69(Suppl 7):S521–S528. doi:10.1093/cid/ciz824

Bush K, Bradford PA. Epidemiology of β-lactamase-producing pathogens. Clinical Microbiology Reviews. 2020;33(2):e00047-19. doi:10.1128/CMR.00047-19

Nikaido H. Multidrug resistance in bacteria. Annual Review of Biochemistry. 2009;78:119–146. doi:10.1146/annurev.biochem.78.082907.145923

Li XZ, Plésiat P, & Nikaido H. The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria. Clinical microbiology reviews. 2015; 28(2), 337-418.

Codjoe FS, Donkor ES. Carbapenem resistance: a review. Medical Sciences. 2017;6(1):1. doi:10.3390/medsci6010001

Paterson DL, Bonomo RA. Extended-spectrum β-lactamases: a clinical update. Clinical Microbiology Reviews. 2005;18(4):657–686. doi:10.1128/CMR.18.4.657-686.2005

Bevan ER, Jones AM, Hawkey PM. Global epidemiology of CTX-M β-lactamases: temporal and geographical shifts in genotype. Journal of Antimicrobial Chemotherapy. 2017;72(8):2145–2155.

World Organisation for Animal Health (2025). – Annual Report on Antimicrobial Agents Intended for Use in Animals. 9th Report. Paris, 49 pp. https://doi.org/10.20506/woah.3584. Licence: CC BYSA 3.0 IGO.

Moses VK, Kandi V, Bharadwaj VG, Suvvari TK, Podaralla E. Molecular characterization of Klebsiella pneumoniae clinical isolates through whole-genome sequencing: a comprehensive analysis of serotypes, sequence types, and antimicrobial and virulence genes. Cureus. 2024;16(4).

Clermont O, Dixit OVA, Vangchhia B, Condamine B, Dion S, Bridier-Nahmias A, et al. Characterization and rapid identification of phylogroup G in Escherichia coli, a lineage with high virulence and antibiotic resistance potential. Environmental Microbiology. 2019;21(8):3107–3117.

Poirel L, Jayol A, Nordmann P. Polymyxins: antibacterial activity, susceptibility testing, and resistance mechanisms encoded by plasmids or chromosomes. Clinical Microbiology Reviews. 2017;30(2):557–596.

Olaitan AO, Morand S, Rolain JM. Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria. Frontiers in Microbiology. 2014;5:116005.

Liu YY, Wang Y, Walsh TR, et al. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. The Lancet Infectious Diseases. 2016;16(2):161–168.

Wang C, Feng Y, Liu L, et al. Identification of novel mobile colistin resistance gene mcr-10. Emerging Microbes & Infections. 2020;9(1):508–516.

Shen Y, Zhang R, Schwarz S, Wu C, Shen J, Walsh TR, Wang Y. Farm animals and aquaculture: significant reservoirs of mobile colistin resistance genes. Environmental Microbiology. 2020;22(7):2469–2484.

Dhaouadi S, Romdhani A, Bouglita W, Chedli S, Chaari S, Soufi L, et al. High biofilm-forming ability and clonal dissemination among colistin-resistant Escherichia coli isolates recovered from cows with mastitis, diarrheic calves, and chickens with colibacillosis in Tunisia. Life. 2023;13(2):299.

Ramírez-Castillo FY, Guerrero-Barrera AL, & Avelar-González F J. An overview of carbapenem-resistant organisms from food-producing animals, seafood, aquaculture, companion animals, and wildlife. Frontiers in veterinary science, (2023). 10, 1158588.

Braun SD, Ahmed MFE, El-Adawy H, Hotzel H, Engelmann I, Weiß D, et al. Surveillance of extended-spectrum beta-lactamase-producing Escherichia coli in dairy cattle farms in the Nile Delta, Egypt. Frontiers in Microbiology. 2016;7:1020.

Tshitshi L, Manganyi MC, Montso PK, Mbewe M, Ateba CN. Extended spectrum beta-lactamase-resistant determinants among carbapenem-resistant Enterobacteriaceae from beef cattle in the North West Province, South Africa: a critical assessment of their possible public health implications. Antibiotics. 2020;9(11):820.

Carfora V, Diaconu EL, Ianzano A, Di Matteo P, Amoruso R, Dell'Aira E, et al. The hazard of carbapenemase (OXA-181)-producing Escherichia coli spreading in pig and veal calf holdings in Italy in the genomics era: risk of spill over and spill back between humans and animals. Frontiers in Microbiology. 2022;13:1016895.

Ben Haj Yahia A, Tayh G, Landolsi S, Maamar E, Galai N, Landoulsi Z, Messadi L. First report of OXA-48 and IMP genes among extended-spectrum beta-lactamase-producing Escherichia coli isolates from diarrheic calves in Tunisia. Microbial Drug Resistance. 2023;29(4):150–162.

Ghatak S, Singha A, Sen A, Guha C, Ahuja A, Bhattacharjee U, et al. Detection of New Delhi metallo-beta-lactamase and extended-spectrum beta-lactamase genes in Escherichia coli isolated from mastitic milk samples. Transboundary and Emerging Diseases. 2013;60(5):385–389.

Yaici L, Haenni M, Saras E, Boudehouche W, Touati A, Madec JY. blaNDM-5-carrying IncX3 plasmid in Escherichia coli ST1284 isolated from raw milk collected in a dairy farm in Algeria. Journal of Antimicrobial Chemotherapy. 2016;71(9):2671–2672.

He T, Wang Y, Sun L, Pang M, Zhang L, Wang R. Occurrence and characterization of blaNDM-5-positive Klebsiella pneumoniae isolates from dairy cows in Jiangsu, China. Journal of Antimicrobial Chemotherapy. 2016;72(1):90–94.

Liakopoulos A, Van Der Goot J, Bossers A, Betts J, Brouwer MSM, Kant A, et al. Genomic and functional characterisation of IncX3 plasmids encoding blaSHV-12 in Escherichia coli from human and animal origin. Scientific Reports. 2018;8(1):7674.

Vikram A, Schmidt JW. Functional blaKPC-2 sequences are present in US beef cattle feces regardless of antibiotic use. Foodborne Pathogens and Disease. 2018;15(7):444–448.

Murugan MS, Sinha DK, Kumar ORV, Yadav AK, Pruthvishree BS, Vadhana P, et al. Epidemiology of carbapenem-resistant Escherichia coli and first report of blaVIM carbapenemases gene in calves from India. Epidemiology & Infection. 2019;147:e159.

Aslantaş Ö, Elmacıoğlu S, Eş Y. Prevalence and characterization of ESBL- and AmpC-producing Escherichia coli from cattle. Kafkas Üniversitesi Veteriner Fakültesi Dergisi. 2016;23(1).

Babacan O. First detection of carbapenem resistance in Enterobacteriaceae isolates isolated from dairy cows' mastitis infection in Türkiye. Ankara Üniversitesi Veteriner Fakültesi Dergisi. 2022;70(1):65–74.

Muller A, Bertrand X, Rogues AM, Péfau M, Alfandari S, Gauzit R, et al. Higher third-generation cephalosporin prescription proportion is associated with lower probability of reducing carbapenem use: a nationwide retrospective study. Antimicrobial Resistance & Infection Control. 2018;7:1–10.

Kelly AM, Mathema B, Larson EL. Carbapenem-resistant Enterobacteriaceae in the community: a scoping review. International Journal of Antimicrobial Agents. 2017;50(2):127–134.

Li Q, Wang H, Xu Y, Bai X, Wang J, Zhang Z, et al. Multidrug-resistant Escherichia albertii: co-occurrence of β-lactamase and MCR-1 encoding genes. Frontiers in Microbiology. 2018;9:258.

Gupta CL, Blum SE, Kattusamy K, Daniel T, Druyan S, Shapira R, et al. Longitudinal study on the effects of growth-promoting and therapeutic antibiotics on the dynamics of chicken cloacal and litter microbiomes and resistomes. Microbiome. 2021;9:1–19.

Alegría Á, Arias-Temprano M, Fernández-Natal I, Rodríguez-Calleja JM, García-López ML, Santos JA. Molecular diversity of ESBL-producing Escherichia coli from foods of animal origin and human patients. International Journal of Environmental Research and Public Health. 2020;17(4):1312.

Doi Y, Iovleva A, Bonomo RA. The ecology of extended-spectrum β-lactamases (ESBLs) in the developed world. Journal of Travel Medicine. 2017;24(suppl_1):S44–S51.

Woerther PL, Burdet C, Chachaty E, Andremont A. Trends in human fecal carriage of extended-spectrum β-lactamases in the community: toward the globalization of CTX-M. Clinical Microbiology Reviews. 2013;26(4):744–758.

Bastidas-Caldes C, Ochoa J, Guerrero-Latorre L, Moyota-Tello C, Tapia W, Rey-Pérez JM, Baroja MI. Removal of extended-spectrum beta-lactamase-producing Escherichia coli, ST98, in water for human consumption by black ceramic water filters in low-income Ecuadorian highlands. International Journal of Environmental Research and Public Health. 2022;19(8):4736.

Peirano G, Richardson D, Nigrin J, McGeer A, Loo V, Toye B, et al. High prevalence of ST131 isolates producing CTX-M-15 and CTX-M-14 among extended-spectrum-β-lactamase-producing Escherichia coli isolates from Canada. Antimicrobial Agents and Chemotherapy. 2010;54(3):1327–1330.

Kutlu HH, Us E, Tekeli A. Bir üniversite hastanesinde 2010-2014 yılları arasında izole edilen Enterobacteriaceae türlerinin karbapenemaz genlerinin araştırılması ve moleküler epidemiyolojisinin belirlenmesi. Mikrobiyol Bul. 2018;52(1):1–12.

Koreň J, Andrezál M, Drahovská H, Hubenáková Z, Liptáková A, Maliar T. Next-generation sequencing of carbapenem-resistant Klebsiella pneumoniae strains isolated from patients hospitalized in the university hospital facilities. Antibiotics. 2022;11(11):1538.

Joddha HB, Mathakiya RA, Joshi KV, Khant RB, Golaviya AV, Hinsu AT, et al. Profiling of antimicrobial resistance genes and integron from Escherichia coli isolates using whole genome sequencing. Genes. 2023;14(6):1212.

Peng Z, Hu Z, Li Z, Zhang X, Jia C, Li T, et al. Antimicrobial resistance and population genomics of multidrug-resistant Escherichia coli in pig farms in mainland China. Nature Communications. 2022;13(1):1116.

Clermont O, Bonacorsi S, Bingen E. Rapid and simple determination of the Escherichia coli phylogenetic group. Applied and Environmental Microbiology. 2000;66(10):4555–4558.

Gordon DM. The influence of ecological factors on the distribution and the genetic structure of Escherichia coli. EcoSal Plus. 2004;1(1).

Müştak HK, Günaydin E, Kaya İB, Salar MÖ, Babacan O, Önat K, et al. Phylo-typing of clinical Escherichia coli isolates originating from bovine mastitis and canine pyometra and urinary tract infection by means of quadruplex PCR. Veterinary Quarterly. 2015;35(4):194–199.

Published

October 15, 2026

License

License